• Strategic Technologies

Display 41 results

27 Jan 20
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent, Access To Medicines

Influencing and shaping our sector | BIA update: October 2019 - January 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.

19 Jan 20
Regulatory, Finance Tax Investment, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent

UK life sciences: Catalysing investment and growth

This updated interim report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.

15 Jan 20
Regulatory, Finance Tax Investment, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Access To Medicines, Consultation Response

BIA response to DIT consultation on UK-Japan trade

The BIA has responded to the Department for International Trade (DIT)’s consultation on UK-Japan trade.

11 Nov 19
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Overarching Political Issues, Strategic Technologies, Access To Medicines, Guidance document, Policy Briefing, News Report

BIA biotech manifesto 2019

The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector. 

View more